Healthcare

When he was 17 years old, Joe Landolina created a revolutionary gel. Now, he is 29 years old and co-founder and CEO of Cresilon, his homegrown Brooklyn-based biotech company that recently submitted the gel for FDA 510(k) clearance for human use and raised $38.5 million in Series A3 financing last year. DDW’s Megan Thomas caught […]

As we celebrate World Health Day, Lu Rahman looks at some of the key drug discovery and development successes over the last year that have significantly helped improved the health and wellbeing of the global population.   Malaria breakthroughs  According to The World Health Organization (WHO) more than a million people in Africa die from malaria every year, including 3,000 children […]

Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the landmark RECOVERY clinical trial into […]

Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally.  Moving forward  As the world looks to improve public health now and after the pandemic, Spencer will work closely with the senior leadership team […]

2022’s World Cancer Day theme is “Close the Care Gap”1 and is focused on raising awareness of the cancer care equity gap that affects almost everyone, in high as well as low- and middle-income countries, and costs lives. DDW’s Megan Thomas comments on the crisis as well as initiatives that are working to close this gap.  World Cancer Day is a […]

Novartis UK has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given a positive scientific opinion for the investigational treatment asciminib to be made available to appropriate patients under the UK Early Access to Medicines Scheme (EAMS).1  What does this mean?  The decision means that adult patients with Philadelphia chromosome-positive chronic myeloid leukaemia […]

DDW’s Megan Thomas speaks to decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector.   Around this time last year, the first Covid-19 vaccines were authorised for emergency use by organisations such as the FDA1, the EMA2, the MHRA3 and many more internationally. A year before that, Covid-19 […]

Edison Group’s Edison Open House: Global Healthcare 2022 was a three-day event, in association with London Stock Exchange, global law firm Taylor Wessing and OpenExchange, which took place from January 25-27, focusing on 33 companies. Content is now available to stream.  Streaming   Content is now available to stream on Edison’s website and OpenExchange.tv. Attendance is free and anyone […]

Beckley Psytech has announced that the first cohort of psychotherapists have begun training in advance of the expected Phase II clinical trial examining 5-MeO-DMT-assisted psychotherapy in treatment resistant depression (TRD).   The training  The training is being conducted in collaboration with Fluence, an educational platform that provides professional training in psychedelic therapy for psychiatrists, psychotherapists, social workers, and […]

While the research, results and trials often take centre-stage when it comes to drug discovery and development reporting, DDW’s Megan Thomas spotlights the funding and investments which make this possible.   1. US researcher awarded $3.6 million to study antibiotic resistance  Sanford Burnham Prebys professor Andrei Osterman, Ph.D., has been awarded a $3.6 million grant from the National Institutes […]